Disease/Infection News

RSS

Study: Bottle feeding appears to increase risk of HPS in infants

Bottle feeding appears to increase the risk infants will develop hypertrophic pyloric stenosis (HPS), a form of stomach obstruction, and that risk seems to be magnified when mothers are older and have had more than one child, according to a study published by JAMA Pediatrics, a JAMA Network publication.

22 Oct 2013

URC leads new project to improve people's health status in Haiti

University Research Co., LLC is leading a new project in Haiti, a country with complex public health issues, including decentralization, HIV/AIDS, and cholera, to improve the population's health status.

22 Oct 2013

Researchers identify agricultural management practices that can reduce contamination risk in produce

Researchers from Cornell University have identified some agricultural management practices in the field that can either boost or reduce the risk of contamination in produce from two major foodborne pathogens: salmonella, the biggest single killer among the foodborne microbes, and Listeria monocytogenes.

22 Oct 2013

Breast milk may protect babies from acquiring HIV infection, say researchers

A substance in breast milk that neutralizes HIV and may protect babies from acquiring HIV from their infected mothers has been identified for the first time by researchers at Duke Medicine.

22 Oct 2013

Parental perceptions pose major barrier to acceptance of HPV vaccination

A Mayo Clinic physician and two other pediatric experts say that parental perceptions pose a major barrier to acceptance of human papillomavirus (HPV) vaccination — and that many of those perceptions are wrong.

22 Oct 2013

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

The National Institute on Drug Abuse has awarded UCLA a $7 million grant to investigate the links between substance abuse and HIV among Latino and African-American men who have sex with men.

22 Oct 2013

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.

21 Oct 2013

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals, Inc. announced today that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients.

21 Oct 2013

HOYA Group's Vision Care Division expands operations in Romania

HOYA Group's Vision Care Division, a key player in the global market for ophthalmic lenses, announces the start of HOYA Lens Romania.

21 Oct 2013

Whitehead Institute scientists discover insidious nature of influenza virus

Revealing influenza's truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its host by first killing off the cells of the immune system that are actually best equipped to neutralize the virus.

21 Oct 2013

Researchers design surface-scanning coil detector for direct bacteria detection on food surfaces

As anyone who has ever consumed bacteria-contaminated food and experienced "food poisoning" can tell you, it's a miserable experience. Yet it's an all-too-common one, with foodborne illnesses making 1 in 6 Americans -- or 48 million people -- sick each year. Of these people sickened, 128,000 end up in the hospital, according to the Centers for Disease Control and Prevention, while 3,000 die.

19 Oct 2013

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.

19 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

New study paves way for patient-specific regenerative therapies for inflammatory bowel diseases

A source of gut stem cells that can repair a type of inflammatory bowel disease when transplanted into mice has been identified by researchers at the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute at the University of Cambridge and at BRIC, the University of Copenhagen, Denmark.

18 Oct 2013

Women with common forms of urinary incontinence have various bacteria in bladder

Women with common forms of urinary incontinence have various bacteria in their bladder, according to data presented today by researchers from Loyola University Chicago Stritch School of Medicine. Researchers also found that some of these bacteria may differ based on their incontinence type.

18 Oct 2013

HBV-infected men more likely to develop liver cancer

A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.

18 Oct 2013

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii. They published their findings recently in PLOS Pathogens.

18 Oct 2013

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.

17 Oct 2013

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Merck, known as MSD outside the United States and Canada, is presenting pharmacokinetic data this week on investigational formulations of a once daily dose of ISENTRESS at the 14th European AIDS Conference, sponsored by the European AIDS Clinical Society.

17 Oct 2013

Disease/Infection News

Study: Bottle feeding appears to increase risk of HPS in infants

URC leads new project to improve people's health status in Haiti

Researchers identify agricultural management practices that can reduce contamination risk in produce

Breast milk may protect babies from acquiring HIV infection, say researchers

Parental perceptions pose major barrier to acceptance of HPV vaccination

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

HOYA Group's Vision Care Division expands operations in Romania

Whitehead Institute scientists discover insidious nature of influenza virus

Researchers design surface-scanning coil detector for direct bacteria detection on food surfaces

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

New study paves way for patient-specific regenerative therapies for inflammatory bowel diseases

Women with common forms of urinary incontinence have various bacteria in bladder

HBV-infected men more likely to develop liver cancer

Atorvastatin drug plus zoledronic acid may help treat toxoplasmosis

Neutra working to help end staph infections in locker rooms

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News